Publications by authors named "David DeBrota"

Claim this Profile
M
Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis.
Kamil Janowski, Elizabeth Shumbayawonda, Andrea Dennis, Matt Kelly, Velicia Bachtiar, David DeBrota

J Pediatr Gastroenterol Nutr· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1.
Jennifer K Leohr, Debra Luffer-Atlas, M Jane Luo, David J DeBrota, Colin Green

J Clin Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
Yuval A Patel, Joanne C Imperial, Andrew J Muir, Quentin M Anstee, David DeBrota

Gastroenterology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.
Christopher D Payne, Mark A Deeg, Melanie Chan, Lai Hock Tan, Elizabeth Smith LaBell, David J DeBrota

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response.
Kenneth A Kobak, Andrew Leuchter, David DeBrota, Nina Engelhardt, Janet B W Williams

J Clin Psychopharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos.
Darcy A Santor, David Debrota, Nina Engelhardt, Steve Gelwicks

Depress Anxiety· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in brain function during administration of venlafaxine or placebo to normal subjects.
Andrew F Leuchter, Ian A Cook, David J DeBrota, Aimee M Hunter, William Z Potter

Clin EEG Neurosci· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it easier to find what you are looking for if you think you know what it looks like?
James C Mundt, John H Greist, James W Jefferson, David J Katzelnick, David J DeBrota

J Clin Psychopharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET).
James C Mundt, David J Debrota, John H Greist

Psychiatry (Edgmont)· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative approach to determine the best behavioral and biological markers of methylphenidate.
Daniel F Hermens, Nicholas J Cooper, C Richard Clark, David Debrota, Simon D Clarke

J Integr Neurosci· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials.
Heidi K Moore, James C Mundt, Jack G Modell, Heidi E Rodrigues, David J DeBrota

J Clin Psychopharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trials.
Nina Engelhardt, Alan D Feiger, Kenneth O Cogger, Dawn Sikich, David J DeBrota

J Clin Psychopharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.
Aimee M Hunter, Andrew F Leuchter, Melinda L Morgan, Ian A Cook, Michelle Abrams, David J DeBrota

Neuropsychopharmacology· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.
Nicholas J Cooper, Hannah Keage, Daniel Hermens, Leanne M Williams, David Debrota

J Integr Neurosci· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.
Kenneth R Evans, Terrence Sills, David J DeBrota, Steve Gelwicks, Nina Engelhardt

J Psychiatr Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.
Craig H Mallinckrodt, Todd M Sanger, Sanjay Dubé, David J DeBrota, Geert Molenberghs

Biol Psychiatry· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis